Dow Up 0.12% Nasdaq Up 1.35%

Agenus Inc. (AGEN)

-NasdaqCM
2.98 0.08(2.76%) Oct 20, 4:00PM EDT
Prev Close:2.90
Open:2.91
Bid:2.13 x 100
Ask:3.19 x 1400
1y Target Est:7.00
Beta:1.82
Next Earnings Date:N/A
Day's Range:2.91 - 3.04
52wk Range:2.27 - 5.27
Volume:165,236
Avg Vol (3m):417,640
Market Cap:186.78M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENUp 2.76%186.78M
ABPI637.26K
DNDN175.64M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):36.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.50
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback